QUARK PHARMACEUTICALS
Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the รขยยBiFARรขยย technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for the occurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the te... chnology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.
QUARK PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Genetics Medical
Founded:
1994-12-01
Address:
Fremont, California, United States
Country:
United States
Website Url:
http://www.quarkpharma.com
Total Employee:
51+
Status:
Active
Contact:
510-402-4020
Email Addresses:
[email protected]
Total Funding:
61.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL LiteSpeed CPanel
Similar Organizations
BIND Therapeutics
BIND Therapeutics isย a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
SBI Asset Management
SBI Asset Management investment in Venture Round - Quark Pharmaceuticals
Tako Ventures
Tako Ventures investment in Series H - Quark Pharmaceuticals
SBI Asset Management
SBI Asset Management investment in Series H - Quark Pharmaceuticals
Tako Ventures
Tako Ventures investment in Series G - Quark Pharmaceuticals
Official Site Inspections
http://www.quarkpharma.com
- Host name: mx.ichsunlinux.cc
- IP address: 182.54.236.106
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
